EMIS Health Implements Open Standards for Interoperability

EMISEMIS Health has become the first UK clinical systems provider to implement new open standards for interoperability in the NHS - enabling clinicians using its systems to securely share data with any other third party system across health and social care.

The announcement at an EMIS Health conference in Stratford-Upon-Avon (3 February 2016) will help the NHS to realise its vision of joined-up care for millions of patients. It follows the company's recent signing of techUK's Interoperability Charter.

From mid-February, the company will begin rolling out an update to its EMIS Web clinical system - used by almost 4,500 GP practices in England and Wales - that allows it to interoperate with any third party supplier who conforms to a published set of open application programme interfaces (APIs). These include the Fast Healthcare Interoperability resources (FHIR) standard and National terminology sets including SNOMED-CT and the NHS Data Dictionary.

In due course, clinicians, whatever IT system they use, with be able to securely share data with colleagues using any of EMIS Health's primary, community, secondary and pharmacy clinical systems.

This milestone puts in place a solid foundation for EMIS Health to rapidly evolve innovative interoperable services. Initially, third party systems will be able to securely obtain real-time primary care patient information, subject to tight information governance controls.

EMIS Group's Chief Medical Officer Dr Shaun O'Hanlon said: "For the last 13 years we have run a highly successful partner programme using our own API to enable integration with third party systems. We are now taking that commitment to a new level - using best practice standards developed by the wider healthcare IT industry as the basis on which we will open up access to our systems for any supplier within the NHS and social care, including NHS Trusts.

"This demonstrates our absolute dedication to freeing up the movement of vital patient information within the NHS to enable more joined-up and informed care. It also supports NHS England chief executive Simon Stevens' determination to make technology an enabler, not a barrier to new ways of organising clinical care."

The unimpeded, secure movement of data across the NHS is a major theme of an independent White Paper presented today by Mark Leaning, Visiting Professor at University College London and an innovator and entrepreneur in healthcare technology.

Related news articles:

About EMIS Health
EMIS Health is part of EMIS Group plc - the UK leader in connected healthcare software and services.

EMIS Health provides software and services to clinicians working across every major UK healthcare setting, including:

  • Primary Care - market leader with 54% share of the UK GP market; its systems hold 40 million cradle to grave patient records;
  • Community Children's and Mental Health Care - 9% and growing UK market share;
  • Secondary Care - 81% of NHS Acute Trusts use an EMIS Health system; its software holds 30 million patient records in A&E alone;
  • Community Pharmacy - the single most used integrated community pharmacy and retail system (36% UK market share);
  • Specialist Care - EMIS Health is the leading provider of software and services to support diabetic eye screening (82% English market share) and other ophthalmology and specialist services.

EMIS Health is an innovator in secure data-sharing to join up healthcare. It was the first in the UK to enable community pharmacists to access information from the GP patient record - supporting safer dispensing - and the first to integrate personal health data captured on wearable consumer devices with the GP patient record.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...